Skip to content
Home/Companies/MedTech/Glycotest
GL

Glycotest

MedTech·United States·Active·14yr hold

Glycotest is a MedTech company, headquartered in United States.

Entry
2012
Hold
14yr
Status
Active
Est. EV
–

Who owns Glycotest?

Glycotest is currently owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage), since 2012.

Hand-verified · updated 2026-07-17

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorMedTech
StatusActive

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021
Martlet Capital
Active
FinancialsUK· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Custom Surgical
Active
ZEISS VenturesGermany· 2026
DiappyMed
Active
Irdi Capital-InvestissementFrance· 2026
Hipp Technology Group
Active
Deutsche Beteiligungs AGGermany· 2026
Data refreshed weekly · Sourced from public filings